🇺🇸 FDA
Patent

US 6242418

Therapeutic uses of BPI protein products for human meningococcemia

expired A61KA61K38/1751A61P

Quick answer

US patent 6242418 (Therapeutic uses of BPI protein products for human meningococcemia) held by The Board of Regents of the University of Texas System expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/1751, A61P, A61P31/00